WuXi Biologics (Cayman) (OTCMKTS:WXXWY) Stock Price Up 4.8% – What’s Next?

Posted by on Sep 15th, 2026

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s stock price shot up 4.8% on Tuesday . The stock traded as high as $12.5850 and last traded at $12.5850. Approximately 2,049 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 70,663 shares. The stock had previously closed at $12.01.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has an average rating of “Hold”.

View Our Latest Stock Analysis on WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Stock Down 0.6%

The company’s 50 day moving average is $11.17 and its 200-day moving average is $9.55.

WuXi Biologics (Cayman) Company Profile

(Get Free Report)

WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.

Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.

Read More

Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.